The largest database of trusted experimental protocols

7 protocols using cytofix cytoperm solution

1

Multicolor Flow Cytometry for Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (3×105–5×105/well) were fist incubated in FcBlock (BD Pharmingen) and then with cocktails of antibodies using CD45-APCCy7 (BD Pharmingen, 30-F11), F4/80-PECy5 (eBioscience, BM8), CD11b-AlexaFluor700 (BD Pharmingen, M1/70), MHCII-biotin (eBiosciences, M5/114.15.2) followed by streptavidin-PETexasRed (BD Pharmingen), CD64-PE (BD Pharmingen, X54-5/7.1.1), CX3CR1-unconjugated (AbD Serotec, polyclonal) followed by anti-IgG(H+L)-FITC (Southern Biotech), and anti-IL10-APC (eBiosciences, JES5-16E3), CD3-PECy5 (eBiosciences, 145-2C11), CD4-PECy7 (eBiosciences, GK1.5), CD19-PE (eBiosciences, MB19-1), FoxP3-PE (eBiosciences, FJK-16s), and PD1-PE (eBiosciences, J43). For intracellular staining, cells were fixed and permeabilized with Cytofix-Cytoperm solution (eBiosciences). Flow results were computed with a BD LSR II flow cytometer and data analyses was performed by using the FACS Diva software (BD).
+ Open protocol
+ Expand
2

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were stained with fixable viability dye eFluor® 780 (eBioscience) for 30 min at 4°C, and Fc receptors were blocked with anti-CD16/32 (BioLegend) blocking antibody prior to surface staining with antibodies. Antibodies for surface staining used are listed, mouse: CD45 (30-F11, BioLegend), TCR β (H57-597, BioLegend), CD69 (H1.2F3, eBioscience), CD1d tetramer (NIH); human: CD45 (HI30, eBioscience), TCRα/β (IP26, BioLegend), CD69 (FN50, BioLegend), Vα24 (6B11, BD Bioscience). For intracellular staining, single cell suspensions were stimulated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich), 1 μg/mL ionomycin (Sigma-Aldrich) and 1 μg/mL Golgi stop A (BD Biosciences) for 4 h. After surface staining, cells were fixed and permeabilized with Cytofix/Cytoperm solution (BD biosciences) and further stained intracellularly with human IFNγ (B27, BioLegend) and human IL-4 (MP4-25D2, BioLegend). For Ki67 staining, cells were fixed and permeabilized with Cytofix/Cytoperm solution (eBioscience), and further stained with Ki67 (SolA15, eBioscience). Data were acquired using LSR II (BD Biosciences) and analyzed using the FlowJo software (BD Biosciences).
+ Open protocol
+ Expand
3

Multimodal Flow Cytometry of SCLC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Annexin‐V/PI staining analysis, DMSO‐ or OTS514‐treated SCLC cells were collected, spun down, washed with PBS, and then resuspended in 50 μL of binding buffer containing 2 μL of APC‐conjugated Annexin‐V antibody (eBioscience, San Diego, CA, USA). After 20 min incubation on ice, the cells were further stained with 100 μL of binding buffer containing 1 μL of propidium iodide (PI) (eBioscience). For cleaved caspase‐3 analysis, SCLC cells were prepared as aforementioned and resuspended in 500 μL of Cytofix/Cytoperm solution (eBioscience). After 20 min incubation on ice, the cells were resuspended with 100 μL of buffer containing 20 μL of PE‐conjugated anti‐cleaved caspase‐3 antibody (eBioscience). For neuronal differentiation detection, prepared SCLC cells were stained with FITC‐conjugated anti‐human CD56 antibody (eBioscience) for 20 min at room temperature. To measure expression levels of CD90 surface protein, cells were stained with APC‐conjugated anti‐human CD90 antibody (5E10) (BD Pharmingen) for 15 min at room temperature. After washing with PBS, samples were subjected to flow cytometry instruments (FACS Calibur or FACS LSRII; Becton Dickinson, San Jose, CA, USA) and analyzed using Flow Jo software (Treestar, Ashland, OR, USA).
+ Open protocol
+ Expand
4

Comprehensive Immune Profiling of CD4 T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody (Ab) staining was performed to evaluate the expression of surface markers, transcription factors (T-bet, RORγt and Foxp3) and cytokines (IFNγ and IL-17) in CD4 T cells as described previously (Yang, Weiner, 2009 (link)). Briefly, the cells were first incubated with Abs to the cell-surface markers for 30’ at 4°C, followed by treatment with Cytofix/Cytoperm solution from ebioscience (for T-bet, RORγt and Foxp3) for 1h or BD Bioscience (for IFNγ and IL-17) for 20’–40’. Then cells were stained for transcription factors (T-bet, RORγt and Foxp3) or intracellular cytokines (IFNγ or IL-17) for 30’. Approximately 100,000 live cell events were acquired on a FACSCantoII and analyzed using FlowJo software (Tree Star, Inc.). PE-αIL-17, APC-αIFNγ, Pacific Blue-αT-bet, AF647-αFoxp3, FITC-αCD4, APC-αCD4, Pacific Blue-αCD44 and PE-Cy7-αCD25 were purchased from Biolegend. Fixable Viability Dye eFluor 780 and PE-αRORγt were purchased from eBioscience.
+ Open protocol
+ Expand
5

Murine Splenic Treg Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen were obtained from the mice and processed to achieve single cell suspensions by pressing the spleen through a 40-μm cell strainer in PBS. The red blood cells in splenic suspensions were lysed with 0.75% NH4Cl and Tris buffer (0.02%) (pH = 7.4) for 5 min. For surface staining, splenocytes were first incubated with PE-Cy5-conjugated anti–mouse CD4 and APC-conjugated anti–mouse CD25 (ebioscience) for 30 min at 4 °C. Cells were further fixed and permeabilized with Cytofix/Cytoperm solution (Catalog, 85-00-5523-00, ebioscience). Then, cells were stained with PE-conjugated anti-mouse Foxp3 (ebioscience), Brilliant Violet 421™-conjugated anti-mouse IL-10 (Biolegend), and Brilliant Violet 421™-conjugated anti-mouse TGF-β (Biolegend) for 30 min at 4 °C. Cells were analyzed using a BD FACSort flow cytometer (BD Biosciences) by gating CD4+ cells and examining the percentage of CD25+Foxp3+ Treg as well as IL10+/TGF-β + Treg. A minimum of 30,000 events was acquired for each sample. Isotype-matched control antibodies were used to determine the cut-off between negative and positive populations. Data were analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells were stained with fluorochrome-labeled monoclonal mouse anti-human antibodies (mAb) against surface antigens (CD3-Energy Coupled Dye (ECD, Beckman Coulter, clone UCHT1), CD4-Pacific Orange (BD Biosciences, clone SK3), CD8-FITC (BD Biosciences, clone HIT8a), CD19 (Invitrogen, clone SJ25-C1)/CD14 Invitrogen, clone TüK4)/Vivid-Pacific Blue, CD45RA Quantum Dots (Qdot) 655 (clone 5H3), and CD62L APC-EF780 (eBiosciences, clone DREG-56), followed by fixation/permeabilization by using cytofix/cytoperm solution (eBiosciences) and intracellular staining with mAb to IFN-γ-APC (BD Biosciences, clone B27), IL-2-phycoerythrin (PE)-Cy7 (BD Biosciences, clone MQ1-17H12), TNF Alexa Flour 700 (BD Biosciences, clone Mab11), IL-17A PerCP-Cy5.5 (eBiosciences, clone eBio64DEC17), and CD69-PE (eBiosciences, clone FN50).
+ Open protocol
+ Expand
7

Quantifying Lymphocyte Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Ki-67 staining, single cell suspensions from draining lymph nodes were surface stained with anti-CD8, anti-CD44 and gB-tetramer. For intracellular Ki-67 staining the cells were fixed and permeabilized by incubating in cytofix/cytoperm solution (eBioscience) followed by staining with FITC-conjugated Ki-67 mAb (BD) or appropriate isotype control (BD).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!